Join the club for FREE to access the whole archive and other member benefits.

Ming Guo

Professor of neurology, molecular and medical pharmacology at the David Geffen School of Medicine at UCLA

Ming Guo, M.D., Ph.D., is P. Gene & Elaine Smith Chair in Alzheimer's Disease Research.

As a practicing Neurologist, she sees patients with memory disorders, neurodegenerative and neurogenetic disorders, referred from both domestic and international sources.

As a researcher, her lab investigates molecular mechanisms of the two most common neurodegenerative disorders, Alzheimer's and Parkinson's disease. Mutations in PINK1 and PARKIN lead to inherited forms of Parkinson's disease. Her lab is one of the first two labs worldwide to report the function of PINK1, and to discover that PINK1, a mitochondria-localized serine-threonine kinase, and PARKIN, an E3 ubiquitin ligase, act in a common genetic pathway to regulate mitochondrial integrity and mitochondrial quality control.

Visit website: https://bioscience.ucla.edu/people/ming-guo/

 ming-guo-26aa8a217

See also: Academia David Geffen School of Medicine at UCLA - Accredited medical school at UCLA.

Details last updated 07-Apr-2022

Ming Guo News

Senior UCLA scientists public states aim to fight aging to impact numerous diseases

Senior UCLA scientists public states aim to fight aging to impact numerous diseases

University of California, Los Angeles (UCLA) - 24-Mar-2022

Great to see the concept of reversing aging becoming a mainstream ambition - it hasn't always been that way!

Topics mentioned on this page:
Ageing Research, Alzheimer's Disease